NKGen Biotech, Inc. Common Stock (NKGN)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 13.65M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
0
52W High
$ 0.96
52W Low
$ 0.10
Dividend Yield
0.00%
Beta
1.18
Technicals
50-Day MA
0.1804
200-Day MA
0.3102
52 Week High
0.9649
52 Week Low
0.098
About NKGN
NKGen Biotech, Inc., a clinical-stage biotechnology company, develops cell therapies for neurodegenerative and oncological diseases based on activated natural killer (NK) cells.
Employees
63
Headquarters
Santa Ana, CA
CEO
Dr. Paul Y. Song M.D.